151 related articles for article (PubMed ID: 11590975)
1. Violent acts associated with fluvoxamine treatment.
Okada F; Okajima K
J Psychiatry Neurosci; 2001 Sep; 26(4):339-40. PubMed ID: 11590975
[No Abstract] [Full Text] [Related]
2. Citalopram and fluvoxamine in Tourette's disorder.
Bajo S; Battaglia M; Pegna C; Bellodi L
J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230-1. PubMed ID: 10087681
[No Abstract] [Full Text] [Related]
3. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Nair NP; Bakish D; Saxena B; Amin M; Schwartz G; West TE
Anxiety; 1996; 2(4):192-8. PubMed ID: 9160622
[TBL] [Abstract][Full Text] [Related]
4. Complex movement disorder associated with fluvoxamine.
Bronner IM; Vanneste JA
Mov Disord; 1998 Sep; 13(5):848-50. PubMed ID: 9756160
[No Abstract] [Full Text] [Related]
5. Fluvoxamine for symptomatic outpatients with COVID-19.
Wu PE; Austin E; Leong D
CMAJ; 2022 Feb; 194(7):E258. PubMed ID: 35045990
[No Abstract] [Full Text] [Related]
6. Increased libido in a woman treated with fluvoxamine: a case report.
Hori H; Yoshimura R; Nakamura J
Acta Psychiatr Scand; 2001 Apr; 103(4):312-4. PubMed ID: 11328247
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluvoxamine on panic disorder.
Hoehn-Saric R; McLeod DR; Hipsley PA
J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
[TBL] [Abstract][Full Text] [Related]
8. Restlessness related to SSRI withdrawal.
Hirose S
Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
[TBL] [Abstract][Full Text] [Related]
9. Seizure possibly associated with fluvoxamine.
Kim KY; Craig JM; Hawley JM
Ann Pharmacother; 2000 Nov; 34(11):1276-8. PubMed ID: 11098342
[TBL] [Abstract][Full Text] [Related]
10. A display of hypomania in a depressed male in response to fluvoxamine.
Horiguchi T; Sai S
World J Biol Psychiatry; 2001 Oct; 2(4):201-4. PubMed ID: 12587152
[TBL] [Abstract][Full Text] [Related]
11. Serotonin syndrome and fluvoxamine: a case study.
Bastani JB; Troester MM; Bastani AJ
Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
[TBL] [Abstract][Full Text] [Related]
12. Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy.
Nafziger AN; Bertino JS; Goss-Bley AI; Kashuba AD
J Clin Psychiatry; 1999 Mar; 60(3):187-90. PubMed ID: 10192595
[TBL] [Abstract][Full Text] [Related]
13. Childhood trichotillomania. Successful treatment with fluoxetine following an SSRI failure.
Palmer CJ; Yates WR; Trotter L
Psychosomatics; 1999; 40(6):526-8. PubMed ID: 10581985
[No Abstract] [Full Text] [Related]
14. Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction.
Banov MD
J Clin Psychiatry; 1999 Dec; 60(12):866-8. PubMed ID: 10665636
[No Abstract] [Full Text] [Related]
15. Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: two case reports.
Chong SA; Tan CH; Lee HS
J Clin Psychopharmacol; 1997 Feb; 17(1):68-9. PubMed ID: 9004072
[No Abstract] [Full Text] [Related]
16. Two cases of panic disorder responsive to low-dose sertraline.
Orenstein H
Clin Neuropharmacol; 2010 Jul; 33(4):215-6. PubMed ID: 20661029
[No Abstract] [Full Text] [Related]
17. Adverse effects of long-term administration of fluvoxamine on haematology, blood biochemistry and fertility in male albino rats: a possible effect of cessation.
Galal AA; Alam RT; Abd El-Aziz RM
Andrologia; 2016 Nov; 48(9):914-922. PubMed ID: 26771175
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF
J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007
[TBL] [Abstract][Full Text] [Related]
19. Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
Asnis GM; Hameedi FA; Goddard AW; Potkin SG; Black D; Jameel M; Desagani K; Woods SW
Psychiatry Res; 2001 Aug; 103(1):1-14. PubMed ID: 11472786
[TBL] [Abstract][Full Text] [Related]
20. Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors.
Fux M; Taub M; Zohar J
Acta Psychiatr Scand; 1993 Oct; 88(4):235-7. PubMed ID: 8256637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
